Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse
Alle Filter löschen

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1022C3(10)
  2. 10C6(2)
  3. 10G10(2)
  4. 1121B(10)
  5. 11B11(4)
  6. 12B5(2)
  7. 148C09(10)
  8. 164#(10)
  9. 16D7(10)
  10. 16E7#(10)
  11. 17E6#(10)
  12. 17F3(4)
  13. 18#(2)
  14. 18A5(10)
  15. 1B4(10)
  16. 1D11.16.8(2)
  17. 1H4(10)
  18. 1H7(10)
  19. 2339#(10)
  20. 23F2G(10)
  21. 25D2(2)
  22. 2B8(10)
  23. 2c3(2)
  24. 2D9(2)
  25. 3(10)
  26. 30-H12(10)
  27. 30C10(10)
  28. 30H12(2)
  29. 31#(10)
  30. 320-587(10)
  31. 356A11(2)
  32. 368D04(2)
  33. 3B3(2)
  34. 3B6(10)
  35. 3C10(2)
  36. 3H9(10)
  37. 4A4(2)
  38. 5C8(10)
  39. 5E5#(10)
  40. 5F9-G4(10)
  41. 6(10)
  42. 60(10)
  43. 6A7(2)
  44. 6D6(2)
  45. 7(10)
  46. 70(2)
  47. 7A9(10)
  48. 7C6(4)
  49. 81C6(10)
  50. 8A4(2)
  51. 8D4-8(2)
  52. 8D5(10)
  53. 9H4(10)
  54. A12(10)
  55. A14(10)
  56. A2(10)
  57. A4(10)
  58. ab324(10)
  59. ABI793(2)
  60. Abituzumab(3)
  61. ABM109(2)
  62. Abrezekimab(2)
  63. Abrilumab(3)
  64. Adalimumab Beta(3)
  65. ADCT-301(10)
  66. ADCT-602(2)
  67. ADG 153(2)
  68. Afasevikumab(3)
  69. Afelimomab(2)
  70. Aflibercept(2)
  71. Alacizumab(2)
  72. ALX148(2)
  73. AMG 811(3)
  74. Anrukinzumab(3)
  75. AO-176(2)
  76. ARGX-112(3)
  77. Aselizumab(3)
  78. Asunercept(2)
  79. AT-1501(2)
  80. AT001(3)
  81. Atacicept(2)
  82. ATG 031(2)
  83. Atrosimab(3)
  84. Avizakimab(3)
  85. B122(2)
  86. B6H12(10)
  87. BAK209B11(2)
  88. Baminercept Alfa(2)
  89. Basiliximab(3)
  90. BAT6004(2)
  91. BD0801(2)
  92. Bectumomab(2)
  93. Belimumab(3)
  94. Benralizumab(3)
  95. Benufutamab(3)
  96. Bermekimab(3)
  97. Bersanlimab(3)
  98. Bevacizumab(3)
  99. Bexmarilimab(3)
  100. Bifikafusp Alfa(2)
  101. Bimekizumab(3)
  102. BION 1301(2)
  103. Bivatuzumab(3)
  104. BlySmAb-1.1(10)
  105. Brazikumab(3)
  106. Briakinumab(3)
  107. Briobacept(2)
  108. Brolucizumab(2)
  109. BT-063(3)
  110. Burfiralimab(2)
  111. C17.8(2)
  112. C2_2E12(2)
  113. Camidanlumab(3)
  114. Camoteskimab(3)
  115. Canakinumab(3)
  116. Cantuzumab(2)
  117. CAT-02-106(2)
  118. CAT-2200(3)
  119. CC-90002(3)
  120. CDP484(3)
  121. CDP571(2)
  122. CDX-0125-TEI(2)
  123. Cendakimab(3)
  124. Certolizumab(2)
  125. Clazakizumab(3)
  126. Clivatuzumab(3)
  127. CMAB008(3)
  128. CMB-401(2)
  129. CNTO 607(3)
  130. Conatumumab(3)
  131. Conbercept(2)
  132. CYT-91000(2)
  133. D1(10)
  134. D2(4)
  135. D8P1C1(2)
  136. Daclizumab(3)
  137. Dapirolizumab(2)
  138. DC101(12)
  139. Dectrekumab(3)
  140. Denosumab(3)
  141. Depemokimab(3)
  142. Dilpacimab(2)
  143. DISC0280(3)
  144. DLX521(2)
  145. Dovanvetmab(2)
  146. Dreg-55(10)
  147. Drozitumab(3)
  148. DS-8273a(3)
  149. Dupilumab(3)
  150. Dusigitumab(3)
  151. Duvakitug(3)
  152. E4#(20)
  153. Ebdarokimab(3)
  154. Efalizumab(3)
  155. Efdamrofusp Alfa(2)
  156. Eflimrufusp Alfa(2)
  157. Eftozanermin Alfa(2)
  158. Elsilimomab(2)
  159. Emapalumab(3)
  160. ENA2(10)
  161. Enavatuzumab(3)
  162. Enlimomab(3)
  163. Enokizumab(3)
  164. Epitumomab cituxetan(2)
  165. Epratuzumab(5)
  166. Eptinezumab(3)
  167. Erlizumab(3)
  168. ESBA 105(3)
  169. Etanercept(2)
  170. Etokimab(3)
  171. Etrolizumab(3)
  172. F16(10)
  173. Faricimab(2)
  174. FD441.8(10)
  175. Fezakinumab(3)
  176. Fletikumab(3)
  177. Fontolizumab(3)
  178. Fremanezumab(3)
  179. Fresolimumab(3)
  180. Frexalimab(3)
  181. G28-8(10)
  182. G544(10)
  183. G6(2)
  184. GAL-F2(2)
  185. Galcanezumab(3)
  186. Gatipotuzumab(3)
  187. Gevokizumab(3)
  188. Golimumab(3)
  189. GSK679586(3)
  190. Gumokimab(3)
  191. Guselkumab(3)
  192. H2L6(3)
  193. H398(10)
  194. H4H10(2)
  195. H5(10)
  196. H52(2)
  197. H6(20)
  198. HB 9579(10)
  199. HFE7A(10)
  200. HM1.24(10)
  201. hMAK195(3)
  202. HMBD-004A(2)
  203. HMBD-004B(2)
  204. HMFG1(10)
  205. HMPL-a83(2)
  206. hRFB4(2)
  207. HuGAL-F2(3)
  208. hum12G8(2)
  209. HuMax-IL15(3)
  210. huS6F1(2)
  211. HW1(10)
  212. IMA-026(3)
  213. IMC-002(2)
  214. IMC-1C11(2)
  215. ImClone 6.64(3)
  216. IMM01(2)
  217. Immurait-Ll2Mab(3)
  218. Inbakicept(2)
  219. Infliximab(3)
  220. Inolimomab(3)
  221. Inotuzumab(3)
  222. Itepekimab(3)
  223. Iv0058(4)
  224. Ivonescimab(2)
  225. Ixekizumab(3)
  226. JCAR018(2)
  227. JES6-1A12(4)
  228. KHK2866(3)
  229. L117/1(2)
  230. L120/12(2)
  231. L120/30(2)
  232. L19-TNF(3)
  233. Latikafusp(2)
  234. LDP-01(2)
  235. Lebrikizumab(3)
  236. Lemzoparlimab(3)
  237. Lenercept(2)
  238. Letaplimab(3)
  239. Letolizumab(2)
  240. Lexatumumab(3)
  241. Licaminlimab(2)
  242. Ligufalimab(3)
  243. Livmoniplimab(2)
  244. LL2(10)
  245. Lutikizumab(2)
  246. LY2525623(3)
  247. LY3016859(2)
  248. M1295(3)
  249. M17/4(12)
  250. M3A1(2)
  251. M3B8(2)
  252. M971(3)
  253. M972(3)
  254. Mab1(10)
  255. Magrolimab(3)
  256. Manfidokimab(3)
  257. Mapatumumab(3)
  258. MEDI 5117(3)
  259. MEDI2045(3)
  260. MEDI3185(2)
  261. MEDI3622(2)
  262. Mepolizumab(3)
  263. Metelimumab(3)
  264. MIAP410(2)
  265. Mirikizumab(3)
  266. MO82(2)
  267. MOR101(2)
  268. MOR102(2)
  269. Moxetumomab(2)
  270. MP5-20F3(2)
  271. MR-1(2)
  272. MR1/MR-1(10)
  273. N178A/9(2)
  274. N212/17(2)
  275. N212/7(2)
  276. N275/14(2)
  277. N295B/66(2)
  278. N324/2(2)
  279. N384/63(2)
  280. N39B/8(2)
  281. N4/15(2)
  282. N4/49(2)
  283. N83/48(2)
  284. Nacolomab(2)
  285. Natalizumab(3)
  286. Navicixizumab(2)
  287. Neihulizumab(3)
  288. Nerelimomab(3)
  289. Netakimab(3)
  290. NI-1701(2)
  291. NIS793(3)
  292. NOK1/NOK-1(10)
  293. NOK2/NOK-2(10)
  294. Odulimomab(3)
  295. Olamkicept(2)
  296. Olinvacimab(3)
  297. Olokizumab(3)
  298. Ontamalimab(3)
  299. Ontorpacept(2)
  300. Opinercept(2)
  301. OV52.24(10)
  302. Ozoralizumab(2)
  303. P4D2(10)
  304. Pankomab(3)
  305. Parsatuzumab(3)
  306. Pascolizumab(3)
  307. Pateclizumab(3)
  308. PC-61.5.3(2)
  309. PC61/PC61.5.3(10)
  310. Pemtumomab(2)
  311. Perakizumab(3)
  312. PF-03475952(2)
  313. Pinatuzumab(3)
  314. Placulumab(2)
  315. Pritumumab(3)
  316. PS/2(2)
  317. PTX25(10)
  318. Pulocimab(2)
  319. R310(2)
  320. R4-6A2(2)
  321. R6N(10)
  322. RA8(2)
  323. Rademikibart(3)
  324. Radretumab(2)
  325. Ramucirumab(3)
  326. Ranibizumab(2)
  327. REGN1909(2)
  328. Remtolumab(2)
  329. Reslizumab(3)
  330. RFB-4(10)
  331. RG7356(2)
  332. Rilonacept(2)
  333. Risankizumab(3)
  334. RO5458640(3)
  335. RO7296682(2)
  336. Romilkimab(2)
  337. Rovelizumab(2)
  338. Rozipafusp alfa(2)
  339. RTX-003(2)
  340. RTX-CD47(2)
  341. Ruplizumab(3)
  342. S4B6(2)
  343. S4B6-1(2)
  344. SAA0004(20)
  345. SAA0008(10)
  346. SAA0019(10)
  347. SAA0020(10)
  348. SAA0025(10)
  349. SAA0026(10)
  350. SAA0040(10)
  351. SAA0046(10)
  352. SAA0047(10)
  353. SAA0065(10)
  354. SAA0067(10)
  355. SAA0068(10)
  356. SAA0075(10)
  357. SAA0079(10)
  358. SAA0080(10)
  359. SAA0081(10)
  360. SAA0083(10)
  361. SAA0084(10)
  362. SAA0085(10)
  363. SAA0112(10)
  364. SAA0147(10)
  365. SAA0173(10)
  366. SAA0196(2)
  367. SAA0239(2)
  368. SAA0266(2)
  369. SAA0281(2)
  370. SAA0309(2)
  371. SAA0312(10)
  372. SAA0366(10)
  373. SAA0367(10)
  374. SAA0368(10)
  375. SAA0369(10)
  376. SAA0370(10)
  377. SAA0371(10)
  378. SAA0372(10)
  379. SAA0373(10)
  380. SAA0374(10)
  381. SAA0375(10)
  382. SAA0377(10)
  383. SAA0378(10)
  384. SAA0381(10)
  385. SAA0382(10)
  386. SAA0383(10)
  387. SAA0384(10)
  388. SAA0386(10)
  389. SAA0387(10)
  390. SAA0389(10)
  391. SAA0390(10)
  392. SAA0391(10)
  393. SAA0392(10)
  394. SAA0393(10)
  395. SAA0394(10)
  396. SAA0395(10)
  397. SAA0414(10)
  398. SAA0415(10)
  399. SAA0416(10)
  400. SAA0421(10)
  401. SAA0423(10)
  402. SAA0432(10)
  403. SAA0436(10)
  404. SAA0437(10)
  405. SAA0440(10)
  406. SAA0442(10)
  407. SAA0443(10)
  408. SAA0446(10)
  409. SAA0447(10)
  410. SAA0453(10)
  411. SAA0483(10)
  412. SAA0511(10)
  413. SAA0513(10)
  414. SAA0549(10)
  415. SAA0763(10)
  416. SAA0768(2)
  417. SAA0806(10)
  418. SAA0815(10)
  419. SAA1383(10)
  420. SAA1403(10)
  421. SAA1413(10)
  422. SAA1487(10)
  423. SAA1992(10)
  424. SAA2157(10)
  425. SAA2180(10)
  426. SAA2212(10)
  427. SAA2216(10)
  428. SAA2219(10)
  429. SAR-566658(2)
  430. SAR113244(3)
  431. SAR428926(3)
  432. sB24M(2)
  433. Secukinumab(3)
  434. SG404(2)
  435. SGN CD47M(2)
  436. Sibeprenlimab(3)
  437. Siltuximab(3)
  438. Simridarlimab(2)
  439. Sirukumab(3)
  440. SM06(2)
  441. SM3(2)
  442. Sontuzumab(3)
  443. SRF231(2)
  444. SRK-181(3)
  445. SSS-23(10)
  446. ST2146(10)
  447. Stapokibart(3)
  448. STI-003(2)
  449. STI-6643(2)
  450. Suciraslimab(2)
  451. SWA11(10)
  452. T24/31(10)
  453. TAB004(2)
  454. Tabalumab(3)
  455. Tanibirumab(2)
  456. Tarcocimab(2)
  457. TAS266(4)
  458. TAY018(2)
  459. Temtokibart(3)
  460. Tenatumomab(2)
  461. TI-061(2)
  462. Tibulizumab(2)
  463. Tigatuzumab(3)
  464. Tildrakizumab(3)
  465. Tilogotamab(3)
  466. TJ-C4GM(2)
  467. Toralizumab(2)
  468. Torudokimab(3)
  469. Tozorakimab(3)
  470. TQB 2928(2)
  471. Tralokinumab(3)
  472. TTI-621(2)
  473. TTI-622(2)
  474. Tulisokibart(3)
  475. Ulocuplumab(3)
  476. Urabrelimab(3)
  477. Ustekinumab(3)
  478. VAK-694(2)
  479. Vanucizumab(2)
  480. Varisacumab(3)
  481. VB6(10)
  482. VB6-008(2)
  483. Vedolizumab(3)
  484. VFF-18(10)
  485. VGX100(3)
  486. VIS-649(10)
  487. Vopikitug(3)
  488. Vulinacimab(3)
  489. Vunakizumab(3)
  490. Vx-1004(2)
  491. Xeligekimab(2)
  492. Xentuzumab(3)
  493. XmAb 5592(3)
  494. XMG1.2(4)
  495. XOMA 089(2)
  496. XT3.11(2)
  497. YT33(2)
  498. Ziltivekimab(3)
  499. ZL-1201(2)
Applications
Isotype

Cell Biology

5419 Artikel

pro Seite

Seite:
  1. 57
  2. 58
  3. 59
  4. 60
  5. 61
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Research Grade Anti-­Human LGALS9 (HFB200902) Antibody Monoclonal HFB200902 Hu Human ANSY-DHA04302-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human LGALS9 (HFB200901) Antibody Monoclonal HFB200901 Hu Human ANSY-DHA04303-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human LGALS9 (LYT-­200) Antibody Monoclonal LYT-200 Hu Human ANSY-DHA04301-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Infliximab Biosimilars Infliximab Hu ANSY-DHB94403-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Adalimumab Biosimilars Adalimumab Beta Hu Human ANSY-DHB94402-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Fepixnebart Fepixnebart Hu Human ANSY-DHB91502-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Freneslerbart Freneslerbart Fe ANSY-DFK29902-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Mevonlerbart Mevonlerbart Fe ANSY-DFK29901-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Linavonkibart Linavonkibart Hu Human ANSY-DHB91605-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Narlumosbart Narlumosbart Hu Human ANSY-DHA30302-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Nisevokitug Nisevokitug Hu Human ANSY-DHB91606-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Tulisokibart Biosimilars Tulisokibart Hu Human ANSY-DHB54001-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Vilamakitug Vilamakitug Hu Human ANSY-DHB95503-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Zifibancimig Zifibancimig Hu Human ANSY-DHA42308-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Zigakibart Zigakibart Hu Human ANSY-DHB34104-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Camidanlumab Biosimilars Camidanlumab Hu Human ANSY-DHB95803-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Ontamalimab Biosimilars Ontamalimab Hu Human ANSY-DHG54901-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Secukinumab Biosimilars Secukinumab Hu Human ANSY-DHH28802-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Ixekizumab Biosimilars Ixekizumab Hu ANSY-DHH28801-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Benralizumab Biosimilars Benralizumab Hu ANSY-DHF86301-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Lemzoparlimab Biosimilars Lemzoparlimab Hu ANSY-DHG17603-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Letaplimab Biosimilars Letaplimab Hu Human ANSY-DHG17604-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Anti-­Human CD184/­CXCR4 Antibody (MEDI3185) Antibody Monoclonal MEDI3185 Hu Human ANSY-DHF39902-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Simridarlimab Simridarlimab Hu ANSY-DHG17605-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Research Grade Xeligekimab Xeligekimab Hu ANSY-DHH28811-1mg

AntibodySystem 		1 mg Anmelden
Vergleichen
Name Preis
Research Grade Anti-­Human LGALS9 (HFB200902) Anmelden Research Grade Anti-Human LGALS9 (HFB200902)
Typ Antibody Monoclonal
Clone HFB200902
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human LGALS9 (HFB200901) Anmelden Research Grade Anti-Human LGALS9 (HFB200901)
Typ Antibody Monoclonal
Clone HFB200901
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human LGALS9 (LYT-­200) Anmelden Research Grade Anti-Human LGALS9 (LYT-200)
Typ Antibody Monoclonal
Clone LYT-200
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Infliximab Anmelden Research Grade Infliximab
Typ Biosimilars
Clone Infliximab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Adalimumab Anmelden Research Grade Adalimumab
Typ Biosimilars
Clone Adalimumab Beta
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Fepixnebart Anmelden Research Grade Fepixnebart
Typ
Clone Fepixnebart
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Freneslerbart Anmelden Research Grade Freneslerbart
Typ
Clone Freneslerbart
Specific against Fe
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Mevonlerbart Anmelden Research Grade Mevonlerbart
Typ
Clone Mevonlerbart
Specific against Fe
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Linavonkibart Anmelden Research Grade Linavonkibart
Typ
Clone Linavonkibart
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Narlumosbart Anmelden Research Grade Narlumosbart
Typ
Clone Narlumosbart
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Nisevokitug Anmelden Research Grade Nisevokitug
Typ
Clone Nisevokitug
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Tulisokibart Anmelden Research Grade Tulisokibart
Typ Biosimilars
Clone Tulisokibart
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Vilamakitug Anmelden Research Grade Vilamakitug
Typ
Clone Vilamakitug
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Zifibancimig Anmelden Research Grade Zifibancimig
Typ
Clone Zifibancimig
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Zigakibart Anmelden Research Grade Zigakibart
Typ
Clone Zigakibart
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Camidanlumab Anmelden Research Grade Camidanlumab
Typ Biosimilars
Clone Camidanlumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Ontamalimab Anmelden Research Grade Ontamalimab
Typ Biosimilars
Clone Ontamalimab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Secukinumab Anmelden Research Grade Secukinumab
Typ Biosimilars
Clone Secukinumab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Ixekizumab Anmelden Research Grade Ixekizumab
Typ Biosimilars
Clone Ixekizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Benralizumab Anmelden Research Grade Benralizumab
Typ Biosimilars
Clone Benralizumab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Lemzoparlimab Anmelden Research Grade Lemzoparlimab
Typ Biosimilars
Clone Lemzoparlimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Letaplimab Anmelden Research Grade Letaplimab
Typ Biosimilars
Clone Letaplimab
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Anti-­Human CD184/­CXCR4 Antibody (MEDI3185) Anmelden Research Grade Anti-Human CD184/CXCR4 Antibody (MEDI3185)
Typ Antibody Monoclonal
Clone MEDI3185
Specific against Hu
Appl.
Host Human
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Simridarlimab Anmelden Research Grade Simridarlimab
Typ
Clone Simridarlimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar
Research Grade Xeligekimab Anmelden Research Grade Xeligekimab
Typ
Clone Xeligekimab
Specific against Hu
Appl.
Host
ArtNr.
Menge 1 mg
Lieferbar

5419 Artikel

pro Seite

Seite:
  1. 57
  2. 58
  3. 59
  4. 60
  5. 61
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top